Covid-19: Novavax set for India launch with Serum Institute of India as manufacturing partner

The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major destination for the shots with the Serum Institute of India as manufacturing partner.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3gvSYAh